Table 1. BMI1P1 expression level in different AML subtypes.

Groups	Subtypes and stages	Subjects		BMI1P1 expression		P
		Number	%	Median	Range
Total AML	Total	144	100	0.039	0–83.090	< 0.001
N = 144	FAB
	M0	1	0.7	0.000	—	—
	M1	10	6.9	0.025	0–3.491	< 0.001
	M2	52	36.1	0.040	0–12.191	< 0.001
	M3	32	22.2	0.079	0–83.092	< 0.001
	M4	29	20.1	0.030	0–35.430	< 0.001
	M5	15	10.4	0.016	0–2.697	< 0.001
	M6	5	3.5	0.169	0–17.308	0.018
WHO
	AML with t(8;21)	9	6.3	0.031	0–3.833	< 0.001
	APL with t(15;17)	30	20.8	0.079	0–83.092	< 0.001
	AML with 11q23 translocation	1	0.7	0.013	—	—
	AML without maturation	9	6.3	0.021	0–3.491	< 0.001
	AML with maturation	42	29.2	0.046	0–12.791	< 0.001
	Acute myelomonocytic leukemia	29	20.1	0.030	0–35.430	< 0.001
	Acute monoblastic and monocytic leukemia	13	9.0	0.036	0–2.697	< 0.001
	Acute erythroid leukemia	4	2.8	0.101	0–17.308	0.046
Control		36	100	9.825	0–660.68	—

P: significance versus control.